These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 33026079)

  • 21. Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats.
    Ackland GL; Yao ST; Rudiger A; Dyson A; Stidwill R; Poputnikov D; Singer M; Gourine AV
    Crit Care Med; 2010 Feb; 38(2):388-94. PubMed ID: 19829100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta blocker effects on heart rate during sleep: a placebo-controlled polysomnographic study with normotensive males.
    Rosen RC; Kostis JB; Seltzer LG; Taska LS; Holzer BC
    Sleep; 1991 Feb; 14(1):43-7. PubMed ID: 1687425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of atenolol and metoprolol on cardiomyocyte apoptosis and related gene expression after acute myocardial infarction in rats].
    Chen YF; Yang YJ; Chen X; Ruan YM; Sun RC; Tian Y; Zhou YW; Wang QZ; Si WX; Chen JL; Gao RL; Chen ZJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):538-43. PubMed ID: 16995309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
    Mutschler E; Spahn H; Kirch W
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):51S-57S. PubMed ID: 6146340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
    Tuininga YS; Crijns HJ; Brouwer J; van den Berg MP; Man in't Veld AJ; Mulder G; Lie KI
    Circulation; 1995 Dec; 92(12):3415-23. PubMed ID: 8521562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium-hydrogen exchange inhibition and beta-blockade additively decrease infarct size.
    Wang P; Zaragoza C; Holman W
    Ann Thorac Surg; 2007 Mar; 83(3):1121-7. PubMed ID: 17307470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-blocking activity of PP-34, a newly synthesized aryloxypropanolamine derivative, and its cardioprotective effect against ischaemia/reperfusion injury in laboratory animals.
    Bhatt LK; Nandakumar K; Bodhankar SL; Bansal J; Piplani P
    J Pharm Pharmacol; 2007 Mar; 59(3):429-36. PubMed ID: 17331347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers.
    Liu XK; Engelman RM; Agrawal HR; Das DK
    J Mol Cell Cardiol; 1991 Oct; 23(10):1091-100. PubMed ID: 1684206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.
    Kawakami K; Nagatomo T; Abe H; Kikuchi K; Takemasa H; Anson BD; Delisle BP; January CT; Nakashima Y
    Br J Pharmacol; 2006 Mar; 147(6):642-52. PubMed ID: 16314852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
    Smith ER; Kacker SR; Raskin A; Yun PT; Davidson JM; Hoffman BB; Clark JT
    Physiol Behav; 1996 Feb; 59(2):241-6. PubMed ID: 8838601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
    Yuan Z; Shioji K; Kihara Y; Takenaka H; Onozawa Y; Kishimoto C
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H83-90. PubMed ID: 14684360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
    Nuttall SL; Routledge HC; Kendall MJ
    J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers.
    Westerlund A
    Eur J Clin Pharmacol; 1985; 28 Suppl():73-6. PubMed ID: 2865153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
    Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-blockers: a review of their pharmacological and physiological diversity in hypertension.
    Ripley TL; Saseen JJ
    Ann Pharmacother; 2014 Jun; 48(6):723-33. PubMed ID: 24687542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of beta-adrenoceptor blockers on growth of neurites in spinal ganglia in organotypic tissue culture.
    Penniyainen VA; Lopatina EV; Tsyrlin VA
    Bull Exp Biol Med; 2007 May; 143(5):556-8. PubMed ID: 18239765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
    Roolvink V; Ibáñez B; Ottervanger JP; Pizarro G; van Royen N; Mateos A; Dambrink JE; Escalera N; Lipsic E; Albarran A; Fernández-Ortiz A; Fernández-Avilés F; Goicolea J; Botas J; Remkes W; Hernandez-Jaras V; Kedhi E; Zamorano JL; Navarro F; Alfonso F; García-Lledó A; Alonso J; van Leeuwen M; Nijveldt R; Postma S; Kolkman E; Gosselink M; de Smet B; Rasoul S; Piek JJ; Fuster V; van 't Hof AWJ;
    J Am Coll Cardiol; 2016 Jun; 67(23):2705-2715. PubMed ID: 27050189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
    Esler M; Kjeldsen SE; Pathak A; Grassi G; Kreutz R; Mancia G
    Blood Press; 2022 Dec; 31(1):210-224. PubMed ID: 36029011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
    Warrington SJ; Holt D; Johnston A; Fitzsimons TJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):37S-44S. PubMed ID: 6146339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.